AT353956B - Verfahren zur herstellung von neuen cephalosporinantibiotika - Google Patents
Verfahren zur herstellung von neuen cephalosporinantibiotikaInfo
- Publication number
- AT353956B AT353956B AT445876A AT445876A AT353956B AT 353956 B AT353956 B AT 353956B AT 445876 A AT445876 A AT 445876A AT 445876 A AT445876 A AT 445876A AT 353956 B AT353956 B AT 353956B
- Authority
- AT
- Austria
- Prior art keywords
- cephalosporinantibiotics
- producing new
- producing
- new
- new cephalosporinantibiotics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB26188/75A GB1555471A (en) | 1975-06-19 | 1975-06-19 | 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA445876A ATA445876A (de) | 1979-05-15 |
| AT353956B true AT353956B (de) | 1979-12-10 |
Family
ID=10239713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT445876A AT353956B (de) | 1975-06-19 | 1976-06-18 | Verfahren zur herstellung von neuen cephalosporinantibiotika |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4074047A (de) |
| JP (1) | JPS5214793A (de) |
| AT (1) | AT353956B (de) |
| AU (1) | AU505041B2 (de) |
| BE (1) | BE843152A (de) |
| CH (1) | CH625526A5 (de) |
| DE (1) | DE2627212A1 (de) |
| DK (1) | DK272676A (de) |
| ES (1) | ES449032A1 (de) |
| FR (1) | FR2315933A1 (de) |
| GB (1) | GB1555471A (de) |
| NL (1) | NL7606614A (de) |
| SE (1) | SE7607037L (de) |
| ZA (1) | ZA763635B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5517823B2 (de) * | 1972-05-16 | 1980-05-14 | ||
| JPS4986668A (de) * | 1972-12-27 | 1974-08-20 | ||
| US4175185A (en) * | 1976-05-19 | 1979-11-20 | Meiji Seika Kaisha Ltd. | Process for preparing cephalosporanic acid derivatives |
| GB1591439A (en) * | 1976-10-01 | 1981-06-24 | Glaxo Operations Ltd | 7-syn (oxyimino -acylamido) cephalosporins |
| US4208517A (en) * | 1976-11-30 | 1980-06-17 | Glaxo Operations Uk Limited | Caphalosporin compounds having at position-7 an α-etherified hydroxyiminoarylacetamido group |
| GB1596278A (en) * | 1976-11-30 | 1981-08-26 | Glaxo Operations Ltd | 7-(-oxyimino-acetamino)cephalosporin derivatives |
| GB1599232A (en) * | 1977-06-03 | 1981-09-30 | Hoffmann La Roche | 7-(2-oximinoacetamido)-cephalosporin derivatives |
| ATE15897T1 (de) * | 1978-07-17 | 1985-10-15 | Fujisawa Pharmaceutical Co | Ausgangsprodukte zur herstellung von cephalosporinen und verfahren zu ihrer herstellung. |
| FI782683A (fi) * | 1978-07-19 | 1980-01-20 | Hoffmann La Roche | Kefalosporinestrar och -estrar |
| US4284631A (en) * | 1978-07-31 | 1981-08-18 | Fujisawa Pharmaceutical Co., Ltd. | 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them |
| US4198504A (en) * | 1978-11-02 | 1980-04-15 | Bristol-Myers Company | [3-(Pyridinium)-7-(naphthyiridinyl carbonylamino)acetamido]cephalosporanic acid derivatives |
| US4337376A (en) * | 1979-12-31 | 1982-06-29 | Broadcom, Incorporated | Communications system and network |
| US7427680B2 (en) * | 2001-01-12 | 2008-09-23 | The Regents Of The University Of California | Fluorogenic substrates for BETA-lactamase gene expression |
| EP1711504A2 (de) | 2004-01-21 | 2006-10-18 | Molecular Probes Inc. | Derivate von cephalosporin und clavulansäure zum nachweis von beta-lactamase in einer probe |
| CN114478149B (zh) * | 2022-01-18 | 2023-09-15 | 吉林化工学院 | 一种羧酸类化合物及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1389194A (en) * | 1971-01-29 | 1975-04-03 | Glaxo Lab Ltd | Antibiotics |
| GB1453049A (en) * | 1973-08-21 | 1976-10-20 | Glaxo Lab Ltd | Cephalosporing antibiotics |
| GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
| US3971778A (en) * | 1972-05-12 | 1976-07-27 | Glaxo Laboratories Limited | Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position |
| DE2262500A1 (de) * | 1972-12-20 | 1973-07-05 | Lilly Co Eli | 3-oxyiminomethylcephalosporinverbindungen |
| IL46302A (en) * | 1973-12-21 | 1978-09-29 | Glaxo Lab Ltd | 7 -( -(etherified oxyimino)-acylamido)cephalosporanic acid derivatives |
-
1975
- 1975-06-19 GB GB26188/75A patent/GB1555471A/en not_active Expired
-
1976
- 1976-06-09 US US05/694,465 patent/US4074047A/en not_active Expired - Lifetime
- 1976-06-18 CH CH784176A patent/CH625526A5/de not_active IP Right Cessation
- 1976-06-18 DE DE19762627212 patent/DE2627212A1/de not_active Withdrawn
- 1976-06-18 ZA ZA763635A patent/ZA763635B/xx unknown
- 1976-06-18 DK DK272676A patent/DK272676A/da not_active Application Discontinuation
- 1976-06-18 FR FR7618662A patent/FR2315933A1/fr active Granted
- 1976-06-18 JP JP51072692A patent/JPS5214793A/ja active Pending
- 1976-06-18 AU AU15032/76A patent/AU505041B2/en not_active Expired
- 1976-06-18 SE SE7607037A patent/SE7607037L/xx unknown
- 1976-06-18 AT AT445876A patent/AT353956B/de not_active IP Right Cessation
- 1976-06-18 NL NL7606614A patent/NL7606614A/xx not_active Application Discontinuation
- 1976-06-18 BE BE168099A patent/BE843152A/xx not_active IP Right Cessation
- 1976-06-18 ES ES449032A patent/ES449032A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5214793A (en) | 1977-02-03 |
| AU1503276A (en) | 1977-12-22 |
| SE7607037L (sv) | 1976-12-20 |
| ES449032A1 (es) | 1977-11-16 |
| BE843152A (fr) | 1976-12-20 |
| FR2315933A1 (fr) | 1977-01-28 |
| DK272676A (da) | 1976-12-20 |
| NL7606614A (nl) | 1976-12-21 |
| AU505041B2 (en) | 1979-11-08 |
| CH625526A5 (de) | 1981-09-30 |
| ZA763635B (en) | 1977-05-25 |
| GB1555471A (en) | 1979-11-14 |
| US4074047A (en) | 1978-02-14 |
| DE2627212A1 (de) | 1977-01-13 |
| FR2315933B1 (de) | 1979-10-12 |
| ATA445876A (de) | 1979-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT351266B (de) | Verfahren zur herstellung von neuen poly- urethanen | |
| AT365579B (de) | Verfahren zur herstellung von neuen tetrahydroisochinoliniumverbindungen | |
| AT360005B (de) | Verfahren zur herstellung von neuen sulfonyl- benzimidazolderivaten | |
| AT344896B (de) | Verfahren zur herstellung von neuen piperazinyliminorifamycinen | |
| AT362085B (de) | Verfahren zur herstellung von neuen 16- -dehydroandrostan-derivaten | |
| AT349633B (de) | Verfahren zur herstellung von neuen dauno- saminylanthracylcinonen | |
| AT344163B (de) | Verfahren zur herstellung von neuen oxadiazolinon-derivaten | |
| AT353956B (de) | Verfahren zur herstellung von neuen cephalosporinantibiotika | |
| ATA585876A (de) | Verfahren zur herstellung von neuen 2-benzimidazolylcarbamaten | |
| AT360006B (de) | Verfahren zur herstellung von neuen thiazolinylbenzimidazolderivaten | |
| AT347453B (de) | Verfahren zur herstellung von neuen 5-phenyl- oxazolidinon-2-derivaten | |
| AT357704B (de) | Verfahren zur herstellung von neuen depot- -steroidestern | |
| AT344150B (de) | Verfahren zur herstellung von neuen cyclohexylphenylen | |
| AT349141B (de) | Verfahren zur herstellung von neuen rifamyzin- verbindungen | |
| ATA885076A (de) | Verfahren zur herstellung von neuen carbamato- sulfenylcarbamoyfluoriden | |
| AT357169B (de) | Verfahren zur herstellung von neuen oxim- carbamaten | |
| AT358575B (de) | Verfahren zur herstellung von neuen 2- carbalkoxyamino-5(6)-phenyl-sulfonyloxy- -benzimidazolen | |
| AT345801B (de) | Verfahren zur herstellung von neuen 1-phenoxy- 2-acyloxy-3-amino-propanderivaten | |
| AT356298B (de) | Verfahren zur herstellung von neuen 6-amino- methylcholest-5-enen | |
| AT344903B (de) | Verfahren zur herstellung von neuen cephalosporinen | |
| AT342617B (de) | Verfahren zur herstellung von neuen 1-methyl-3-alkyl-7-oxoalkylxanthinen | |
| AT347967B (de) | Verfahren zur herstellung von neuen biguaniden | |
| AT353432B (de) | Verfahren zur herstellung von neuen halogen- pregnadienen | |
| ATA572577A (de) | Verfahren zur herstellung von neuen cyclohexylphenylen | |
| ATA239476A (de) | Verfahren zur herstellung von neuen d-homo- steroiden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |